Holen Sie sich die Stockscreener-App
68.43
3.55%
-2.52
Handel nachbörslich:
69.41
0.98
+1.43%
Schlusskurs vom Vortag:
$70.95
Offen:
$71.6
24-Stunden-Volumen:
967.32K
Relative Volume:
0.66
Marktkapitalisierung:
$6.13B
Einnahmen:
$288.07M
Nettoeinkommen (Verlust:
$22.31M
KGV:
483.26
EPS:
0.1416
Netto-Cashflow:
$41.15M
1W Leistung:
+2.32%
1M Leistung:
-2.92%
6M Leistung:
+86.92%
1J Leistung:
+204.81%
1-Tages-Spanne:
$67.55
$71.81
1-Wochen-Bereich:
$65.74
$71.81
52-Wochen-Spanne:
$21.14
$93.61
Liquidia Corp Stock (LQDA) Company Profile
Firmenname
Liquidia Corp
Sektor
Telefon
919.328.4400
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA vs TAK, TEVA, HLN, ZTS, VTRS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
68.43 | 6.13B | 288.07M | 22.31M | 41.15M | 0.1416 |
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-15 | Fortgesetzt | Jefferies | Buy |
| 2025-05-19 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | Eingeleitet | Raymond James | Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Perform |
| 2024-01-05 | Bestätigt | Needham | Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Underperform |
| 2022-09-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2022-07-22 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-05-31 | Eingeleitet | BTIG Research | Buy |
| 2022-05-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-11-08 | Fortgesetzt | Jefferies | Buy |
| 2018-09-05 | Eingeleitet | Wedbush | Outperform |
| 2018-08-20 | Eingeleitet | Jefferies | Buy |
| 2018-08-20 | Eingeleitet | Needham | Buy |
Alle ansehen
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
LQDA News | LIQUIDIA CORP (NASDAQ:LQDA) - ChartMill
Is It Too Late to Buy Liquidia Corp (LQDA) After 5.1% Rally? GF Value Says Undervalued - GuruFocus
Liquidia Corporation (LQDA) Stock Forecasts - Yahoo! Finance Canada
Can LQDA's Yutrepia Outpace Intensifying PAH Competition? - finance.yahoo.com
Liquidia Corp (LQDA) Shares Surge 3.3% -- What GF Score of 70 Te - GuruFocus
Form 144 LIQUIDIA CORPORATION For: 22 September By Investing.com - Investing.com Canada
Liquidia (NASDAQ:LQDA) Rating Increased to Buy at Wall Street Zen - MarketBeat
Liquidia (NASDAQ:LQDA): Strong Growth Paired With Technical Setup Quality - ChartMill
Liquidia Corp (LQDA) Shares Surge 4.1% -- What GF Score of 70 Te - GuruFocus
Liquidia (NASDAQ:LQDA) Director Raman Singh Sells 9,024 Shares - MarketBeat
Option exercises and share sales by Liquidia (NASDAQ: LQDA) director - Stock Titan
Squarepoint Ops LLC Trims Stock Position in Liquidia Corporation $LQDA - MarketBeat
California State Teachers Retirement System Acquires 1,657 Shares of Liquidia Corporation $LQDA - MarketBeat
Liquidia CEO Roger Jeffs Says Demand For Inhaled Lung Disease Drug Is Growing Amid Q2 Revenue Beat - Stocktwits
Liquidia (NASDAQ:LQDA) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat
Director at Liquidia (NASDAQ: LQDA) plans $619K stock sale - Stock Titan
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now? - Yahoo Finance
Liquidia Corporation $LQDA Holdings Decreased by Opaleye Management Inc. - MarketBeat
Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio? - Yahoo Finance
What Could Put Liquidia (NASDAQ:LQDA) On A New Path? - Kalkine Media
LQDA - Finviz
LIQUIDIA CORP (NASDAQ:LQDA) Fits the Affordable Growth Screen - ChartMill
Liquidia at Wells Fargo 21st annual healthcare conference: growth and pipeline - Investing.com India
Wellington Management Group LLP Sells 22,925 Shares of Liquidia Corporation $LQDA - MarketBeat
Liquidia Corp Stock Intrinsic Values - GuruFocus
Does FDA Fast Track For YUTREPIA In SSc Raynaud’s Change The Bull Case For Liquidia (LQDA)? - Yahoo Finance
Is Liquidia (LQDA) Still Undervalued As Fast Track News Tests Its Valuation? - Yahoo Finance
Liquidia (LQDA) Stock Looks Stretched On Earnings But Reasonable On Broader Checks - Yahoo Finance
Liquidia Corp CHRO Sarah Krepp Sells 274 Shares Under Pre-Set 10b5-1 Trading Plan - kalkinemedia.com
Liquidia Corp (NASDAQ: LQDA) Secures FDA Fast Track for YUTREPIA Targeting Raynaud’s Phenomenon in Up to 90% of Systemic Sclerosis Patients - Kalkine Media
How Does Liquidia Corporation's (NASDAQ:LQDA) PRINT Platform Actually Work? - Kalkine Media
Why Is Liquidia Stock Gaining Thursday?Liquidia (NASDAQ:LQDA) - Benzinga
Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations - Yahoo Finance
LQDA Looks 75.0% Undervalued on GF Value™ - GuruFocus
Liquidia’s YUTREPIA Receives FDA Fast Track Designation for Systemic Sclerosis-Associated Raynaud’s Phenomenon - Quiver Quantitative
Liquidia Gets FDA Fast Track for YUTREPIA Raynaud's | LQDA Stock News - Stock Titan
Liquidia Corporation $LQDA Shares Sold by Pale Fire Capital SE - MarketBeat
Liquidia Corporation (NASDAQ:LQDA) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress - finance.yahoo.com
Two lung-disease studies will be presented in Barcelona - Stock Titan
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference - The Manila Times
Liquidia Corp Stock Operating Data - GuruFocus
Can LQDA's Yutrepia Sustain Growth Amid Fierce PAH Competition? - finance.yahoo.com
Q1 2025 Liquidia Corp Earnings Call Transcript - GuruFocus
Liquidia Corp (HAM:LT4) Valuation: Possible Value Trap, Think Twice - GuruFocus
Is the Options Market Predicting a Spike in Liquidia Stock? - finance.yahoo.com
Liquidia Corp (HAM:LT4)Valuation Measures & Financial Statistics - GuruFocus
HAM:LT4 Dividend: Does Liquidia Corp Pay a Dividend? - GuruFocus
Who's Buying or Selling Liquidia Corp (HAM:LT4) Stock Today? - GuruFocus
Liquidia Corp (HAM:LT4) Stock Price & 30 Year Financial Data - GuruFocus
Liquidia Corp (HAM:LT4) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Finanzdaten der Liquidia Corp-Aktie (LQDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):